The store will not work correctly when cookies are disabled.
(R)-N-(4-acetyl-5-methyl-5-phenyl-4,5-dihydro-1,3,4-thiadiazol-2-yl)acetamide
ID: ALA4295046
PubChem CID: 686906
Max Phase: Preclinical
Molecular Formula: C13H15N3O2S
Molecular Weight: 277.35
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(=O)NC1=NN(C(C)=O)[C@@](C)(c2ccccc2)S1
Standard InChI: InChI=1S/C13H15N3O2S/c1-9(17)14-12-15-16(10(2)18)13(3,19-12)11-7-5-4-6-8-11/h4-8H,1-3H3,(H,14,15,17)/t13-/m1/s1
Standard InChI Key: JEFVYQYZCAVNTP-CYBMUJFWSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
8.3204 -9.1586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5642 -10.7813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2063 -10.2670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5074 -7.5107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7251 -8.9512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0834 -9.4602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6749 -9.6668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2306 -8.9346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6907 -7.5889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8466 -6.7586 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.4518 -8.6744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8351 -9.2183 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.2856 -7.8705 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.9891 -8.1764 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.8091 -8.1778 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.7961 -10.4794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9620 -8.6485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0563 -8.9622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3892 -9.4380 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4 10 2 0
2 3 2 0
3 6 1 0
12 11 1 0
15 14 1 0
1 7 1 0
5 6 1 0
14 5 1 0
19 18 1 0
7 16 2 0
16 2 1 0
14 4 1 0
6 1 2 0
4 9 1 0
11 8 1 0
11 13 2 0
5 17 1 1
18 15 2 0
5 19 1 0
18 12 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 277.35 | Molecular Weight (Monoisotopic): 277.0885 | AlogP: 1.86 | #Rotatable Bonds: 1 |
Polar Surface Area: 61.77 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.68 | CX Basic pKa: ┄ | CX LogP: 1.79 | CX LogD: 1.79 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.85 | Np Likeness Score: -0.65 |
References
1. Talapatra SK, Tham CL, Guglielmi P, Cirilli R, Chandrasekaran B, Karpoormath R, Carradori S, Kozielski F.. (2018) Crystal structure of the Eg5 - K858 complex and implications for structure-based design of thiadiazole-containing inhibitors., 156 [PMID:30031975] [10.1016/j.ejmech.2018.07.006] |